Monthly Archives: June 2020

VerifyMe Announces Pricing of $10.0 Million Public Offering, Uplisting to NASDAQ and 50-to-1 Reverse Stock Split

ROCHESTER, NY / ACCESSWIRE / June 17, 2020 / VerifyMe, Inc. (NASDAQ:VRME)(NASDAQ:VRMEW) ("VerifyMe" or the "Company"), a technology solutions provider specializing in brand protection functions such as counterfeit prevention, authentication, serialization, track and trace features for labels, packaging and products, today announced the pricing of its underwritten public offering of 2,173,913 units at a price to the public of $4.60 per unit. Each unit issued in the offering consists of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $4.60. The common stock and warrants are immediately separable, will be issued separately, and are expected to begin trading on the Nasdaq Capital Market on June 18, 2020, under the symbols "VRME" and "VRMEW," respectively. VerifyMe expects to receive gross proceeds of $10.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses. Concurrent with the offering, the Company will effectuate a reverse split of its issued and outstanding common stock and treasury stock at a ratio of 50-to-1. The reverse stock split is expected to be effective at 12:01 a.m., Eastern time, on Thursday, June 18, 2020. The share numbers and pricing information in this release are adjusted to reflect the impact of the reverse stock split.

VerifyMe has granted the underwriters a 45-day option to purchase up to 326,087 additional shares of common stock, or additional warrants to purchase 326,087 shares of common stock, or any combination thereof, at the public offering price to cover over-allotments, if any. The offering is expected to close on June 22, 2020, subject to customary closing conditions.

Maxim Group LLC is acting as lead book-running manager for the offering and Joseph Gunnar & Co., LLC is acting as co-book-running manager for the offering.

The registration statement on Form S-1 (File No. 333-234155) relating to this offering was previously filed with and subsequently declared effective by the Securities and Exchange Commission ("SEC") on June 17, 2020. The offering is being made only by means of a prospectus. Copies of the prospectus relating to the offering, when available, may be obtained from Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174, at (212) 895-3745, and will also be available on the SEC's website at http://www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About VerifyMe, Inc.

VerifyMe, Inc., is a technology solutions provider specializing in brand protection functions such as counterfeit prevention, authentication, serialization, track and trace features for labels, packaging and products. VerifyMe's physical technology authenticates packaging, labels and documents with a suite of proprietary security inks and pigments, which work in conjunction with serialization and track-and-trace software known as VeriPAS™ that allows both consumers and brand inspectors to verify authenticity with their smart phones. VeriPAS™ is a serialization software system that brand owners access through a web portal to monitor, control and protect their products complete life cycle. To learn more, visit www.verifyme.com

Cautionary Note Regarding Forward-Looking Statements

This release contains forward-looking statements regarding the timing and success of the proposed offering, the Company's reverse stock split of outstanding shares of common stock and treasury shares, and the timing and financial impact of VerifyMe's ability to implement its business plan, expected revenues and future success. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include our ability to continue as a going concern and history of losses, our ability to obtain additional financing, the impact of the COVID-19 pandemic, intellectual property litigation, the successful development of our sales and marketing capabilities, our ability to retain key management personnel, our ability to work with partners in selling our technologies to businesses, production difficulties, our inability to enter into contracts and arrangements with future partners, issues which may affect the reluctance of companies to change their purchasing of products, acceptance of our technologies, the efficiency of our authenticators in the field, the possibility that our common stock and warrants may not begin trading on the Nasdaq Capital Market as expected and the offering may not close as expected. Further information on our risk factors is contained in our registration statement on Form S-1 (File No. 333-234155) that we have filed with the SEC and the final prospectus, when available. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

CONTACT:

For Licensing or Other Information Contact:

Company: VerifyMe, Inc.

Email: IR@verifyme.com

Website: http://www.verifyme.com

Investors:

ClearThink

nyc@clearthink.capital

SOURCE: VerifyMe

ReleaseID: 594318

Sapience Therapeutics to Present Data on its Two Lead Programs at 2020 AACR Virtual Annual Meeting II

HARRISON, NY / ACCESSWIRE / June 17, 2020 / Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to treat oncology indications, announced today that it will present two posters at the American Association for Cancer Research (AACR) Virtual Meeting II taking place on June 22-24, 2020. Sapience will present preclinical data on its ST101 program and data on its β-catenin antagonist program. Both poster presentations will take place in the Intracellular Pathways as Drug Targets session and will be released on June 22nd for viewing.

Details of the two virtual poster presentations are as follows:

Abstract Title: C/EBPβ antagonist peptide, ST101, attenuates oncogenic gene transactivation in cancer cells to drive antitumor activity
Session Title: Intracellular Pathways as Drug Targets
Abstract Number: 6380
Poster Number: 1817

Abstract Title: β-catenin antagonist peptide attenuates oncogenic gene transactivation and promotes antitumor activity in breast cancer models
Session Title: Intracellular Pathways as Drug Targets
Abstract Number: 7148
Poster Number: 1816

About Sapience Therapeutics

Sapience Therapeutics, Inc., is a privately held, preclinical biotechnology company focused on discovering and developing peptide-based therapeutics for major unmet medical needs, particularly high mortality cancers. With platform-based discovery of peptide therapeutics that disrupt protein-protein interactions, Sapience's molecules hold potential to target intracellular interactions that are traditionally considered "undruggable targets". Its lead compound, ST101, is a first-in-class molecule with potential applications in various solid tumors and hematologic malignancies. In 2016, Sapience Therapeutics closed its Series A financing, which was led by Eshelman Ventures and included investments from Celgene Corporation, TaiAn Technologies Corporation and Healthlink Capital. For more information on Sapience Therapeutics, please visit www.sapiencetherapeutics.com.

Forward-Looking Statements

This press release contains forward-looking statements, and any statements other than statements of historical fact could be deemed to be forward-looking statements. These forward-looking statements may include, among other things, statements regarding future events that involve significant risks and uncertainties. These statements are based on management's current expectations, and actual results and future events may differ materially as a result of certain factors, including, without limitation, risks related to the application of the net proceeds from the offering to Sapience's product development objectives, our ability to obtain additional funds, and meet applicable regulatory standards and receive required regulatory approvals. These are forward-looking statements, which speak only as of the date of this press release. Sapience does not undertake any obligation to update any forward-looking statements as a result of new information, future events, changed assumptions or otherwise.

Contacts:

Sapience Therapeutics, Inc.
Barry Kappel
President and Chief Executive Officer
info@sapiencetherapeutics.com

SOURCE: Sapience Therapeutics, Inc.

ReleaseID: 594122

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ:BPTH)

DALLAS, TX / ACCESSWIRE / June 17, 2020 / Bio-Path Holdings, Inc. (NASDAQ:BPTH).

The full report can be accessed by clicking on the following link: http://stonegateinc.com/reports/BPTH%20JUNE%202020.pdf

Company Description

Bio-Path Holdings, Inc. (Bio-Path) is a clinical stage biotechnology company that focuses on developing nucleic acid cancer therapeutics using its proprietary nanoparticle RNAi antisense technology called DNAbilize®. This technology safely distributes nucleic acid based drugs systemically throughout the body via intravenous infusion. Bio-Path's lead product candidate, prexigebersen (BP1001) is in Phase 2 clinical studies for the treatment of acute myeloid leukemia (AML), and the Company has filed an Investigational New Drug (IND) for a Phase 1 in solid tumors in 2020 (prexigebersen-A). The Company's second DNAbilize® drug candidate, Liposomal Bcl-2 (BP1002), for the treatment of lymphoma, chronic lymphocytic leukemia (CLL), colon, prostate and breast cancers, filed an IND application for a Phase 1 clinical trial in lymphoma and CLL. Bio-Path's IND application for BP1002 has been cleared by the FDA in lymphoma and CLL patients, and first-in-human studies will begin summer 2020. Bio-Path's third drug candidate, BP1003, is currently in preclinical development in a pancreatic patient-derived tumor model with plans to pursue IND-enabling studies and file an IND in 2020, subsequently entering first-in-human trials the following year.

SUMMARY

• Bio-Path's pipeline continues to expand with new cancer indications, and once its DNAbilize® platform is proven successful for cancer, the core technology can easily be expanded to address new therapeutic areas, including autoimmune diseases. BPTH has two issued patents related to its DNAbilize® platform including its use in the treatment of cancers, autoimmune diseases and infectious diseases, and five pending patents.

• In contrast to other lipid delivery technologies that have dose-limiting toxicities, DNAbilize®, Bio-Path's next generation oligonucleotide-based technology, enables the delivery of high doses of therapeutics to target cells, while demonstrating no evidence of toxicity. This lack of toxicity enables the development of therapies to address patients, particularly within the growing elderly population, who are unable to withstand aggressive regimens, and therefore, have limited options.

• Bio-Path has completed Phase 1 clinical trials for its lead candidate prexigebersen for AML, CML and other blood cancers, and is in the midst of a Phase 2 clinical trial for AML. Importantly, in March 2019 the Company announced an update to interim data, reporting that prexigebersen plus LDAC continues to be well-tolerated and now has shown early anti-leukemic activity (revised upwards) in almost 65% of evaluable AML patients; notably, it was observed that 68% of the responding patients were secondary AML patients, historically a very difficult class to treat. Given the new data, BPTH developed a revised registration-directed clinical development plan (see page 4) and recently reported successful completion of safety testing in Stage 2 of the Phase 2 clinical trial for AML.

• The clinical targets for BP1002 have initially been lymphoma and CLL, and potentially breast cancer, colon cancer, and prostate cancer. This novel, non-toxic, specific Bcl-2 inhibitor could be a significant advance in cancer therapeutics, with the potential to treat 40% to 60% of solid tumors, according to Bio-Path estimates. And given the most recent preclinical data, BPTH now believes that BP1002 likely could be used to treat CLL, and AML and CLL patients who have relapsed following treatment with venetoclax. Venetoclax works against the anti-apoptotic protein Bcl-2 by neutralizing the protein's BH3 domain, but some patients relapse due to BH3 domain mutation over time. However, BP1002's activity is based on blocking the Bcl-2 messenger RNA and does not target the BH3 domain; hence, it would likely be able to treat these patients who have relapsed on venetoclax.

• Bio-Path is developing a third drug candidate, BP1003, for the treatment of pancreatic cancer; BP1003 targets the Stat3 protein and is currently in preclinical development in a pancreatic patient-derived tumor model, with previous preclinical models having shown BP1003 to successfully penetrate pancreatic tumors.

• At 3/31/20, BPTH reported cash balance of ~$17.9M, sufficient to achieve key milestones for its programs throughout the upcoming year and likely beyond.

• With promising clinical data and several programs in the pipeline addressing sizable markets with unmet needs, our comparables analysis shows that BPTH remains undervalued at current levels. See page 8 for further details.

About Stonegate Capital Partners

Stonegate Capital Partners is a Dallas-based corporate advisory firm dedicated to serving the specialized needs of small-cap public companies. Since our inception, our mission has been to find innovative, undervalued public companies for our network of leading institutional investors who seek high-quality investment opportunities.

CONTACT:

Laura Engel
(214) 987-4121
laura@stonegateinc.com

SOURCE: Stonegate Capital Partners

ReleaseID: 594129

Global Taxi APP Market 2020 COVID-19 Impact, Key Players, Trends, Sales, Supply, Analysis and Forecast 2026

WiseGuyReports.com adds “Global Taxi APP Market Research Report 2020 Analysis and Forecast 2026” reports to its database.

Pune, India – June 17, 2020 /MarketersMedia/

Taxi APP Market:

Executive Summary

The report lays out a detailed form of database with regard to the recent discoveries and the key technological advancements in the industry, along with the assessment of the impact that these developments can have on the growth prospects of the market. The report primarily focuses on the business conditions coupled with the potential headways as well as the entryways in the global Taxi APP market. In addition to this, the main objective is to present the current price margins along with the challenges that can potentially be faced by the manufacturers during the review period. The continually changing dynamics in the market have also been appraised by the experts. In summary, the report throws light on the market status throughout the forecast period, which starts with 2020, and ends with 2026.

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/5442537-covid-19-impact-on-global-taxi-app-market-size-status-and-forecast-2020-2026

Primary Boosters & Challenges

Apart from offering an in-depth appraisal of the main dynamics that mold the Taxi APP market, the report also outlines the pricing record, volume trends and the market size in the coming years. The significant opportunities, challenges along with the primary boosters are also outlined in the report, for providing an enhanced comprehension of the market.

Regional Study

The opportunities, threats, inadequacies and strengths in the Taxi APP market have been elucidated in the report, with respect to certain regions. Across these regions, the renowned players are working on boosting their profits armed with strategies such as agreements, partnerships and more. The Taxi APP market’s regional study comprises the latest valuation as well as the future growth possibilities. The key regional markets assessed in the report include the Middle East & Africa, Europe, Latin America, North America and Asia Pacific. The oncoming and the latest trends combined with the market size across these regions are provided in this section of the report.

Method of Research

The Taxi APP market research provides hands-on data, after an acute analysis conducted by the experts, who have used the Porter’s Five Force Model’s parameters. Experts’ valuable inputs are outlined in the report, outlining the current norms along with the names of the leading industry participants and the chain network around the world. An extensive review of the parent industry, combined with the growth prospects, governing factors and macro-economic aspects are also covered in the report, in terms of segmentation. The market research has been done using two methods, namely primary and secondary. These methods help achieve a better understanding of the worldwide Taxi APP market, keeping in mind the threats, opportunities, strengths and weaknesses in the industry.

Market Key Player

Innofied Solution
Enuke Software
Uber
Appypie
Tagmytaxi
Mtoag
Mobisoft
Space-O Technologies
Peerbits
TaxiStartup
Yalantis

Table of Content

1 Report Overview

2 Global Growth Trends by Regions

3 Competition Landscape by Key Players

4 Breakdown Data by Type (2015-2026)

5 Taxi APP Breakdown Data by Application (2015-2026)

6 North America

7 Europe

8 China

9 Japan

10 Southeast Asia

11 India

12 Central and South America

13 Key Players Profiles

14 Analyst’s Viewpoints/Conclusions

15 Appendix

Continuous…

For further information on this report, visit – https://www.wiseguyreports.com/reports/5442537-covid-19-impact-on-global-taxi-app-market-size-status-and-forecast-2020-2026

NOTE : Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WiseGuyResearch Consultants Pvt Ltd.
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +1-646-845-9349 (US) +44 208 133 9349 (UK)
Website: https://www.wiseguyreports.com/

Source URL: https://marketersmedia.com/global-taxi-app-market-2020-covid-19-impact-key-players-trends-sales-supply-analysis-and-forecast-2026/88963989

Source: MarketersMedia

Release ID: 88963989

Blood Screening and Typing Market 2020 Global Analysis, Opportunities and Forecast to 2026

New Study Reports “Blood Screening and Typing Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports.

Pune, India – June 17, 2020 /MarketersMedia/

Blood Screening and Typing Market 2020-2026

New Study Reports “Blood Screening and Typing Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports.

Introduction/Report Summary:

This report provides in depth study of “Blood Screening and Typing Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Blood Screening and Typing Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Blood Screening definition: because can transmit a variety of serious infectious diseases such as hepatitis b, hepatitis c, AIDS and syphilis through blood.In order to ensure the safety of blood for clinical use, the quality of blood products, and to prevent cross-infection between blood supplies and the health of workers who collect blood and blood products, it is necessary to prevent the patients infected with the above diseases from entering the blood supply team, and prevent the direct transfusion of plasma positive for the pathogens of the above diseases to patients or for the production of blood products.

Drivers and Constraints

The fundamental dynamics that are explored in the report hold substantial influence over the Blood Screening and Typing market. The report further studies on the value, volume trends, and the pricing history of the market. In addition to it, various growth factors, restraints, and opportunities are also analyzed for the market to study the in-depth understanding of the market.

This report also analyzes the impact of Coronavirus COVID-19 on the Blood Screening and Typing industry.

Key Players

The report has profiled some of the Important players prevalent in the global like – Abbott Laboratories,
Agena Bioscience
Axo Science
Bag Health Care Gmbh
Becton, Dickinson
Bio-Rad Laboratories
Biomerieux
Danaher
Day Medical
Diagast
F. Hoffmann-La Roche
Grifols
Immucor
Novacyt Group
Ortho Clinical Diagnostics
Quotient
Siemens Healthcare
Thermo Fisher Scientific, and more.

This report covers the sales volume, price, revenue, gross margin, manufacturers, suppliers, distributors, intermediaries, customers, historical growth and future perspectives in the Blood Screening and Typing.

Request for Free Sample Report of “Blood Screening and Typing” Market @  https://www.wiseguyreports.com/sample-request/5416645-covid-19-impact-on-global-blood-screening-and

Market Segmentation based On Type, Application and Region:

The global Blood Screening and Typing is analyzed for different segments to arrive at an insightful analysis. Such segmentation has been done based on type, application, and region.

Based on Type, the global Blood Screening and Typing Market is segmented into Nucleic Acid Amplification Technology, Immunohematology, Microbiological Technique and other

Based on Application, the Blood Screening and Typing Market is segmented into Reference Laboratories, Standalone Blood Banks, Hospitals, and Others.

Based on Detailed Regional Analysis, the regional segmentation has been carried out for regions of U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report on WGR includes an in-depth study of the Blood Screening and Typing in each regional segment mentioned above.

Key Stakeholders 
Blood Screening and Typing Market Manufacturers 
Blood Screening and Typing Market Distributors/Traders/Wholesalers 
Blood Screening and Typing Market Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/5416645-covid-19-impact-on-global-blood-screening-and

Major Key Points from Table of Content:

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Blood Screening and Typing Revenue
1.4 Market Analysis by Type
1.4.1 Global Blood Screening and Typing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Nucleic Acid Amplification Technology
1.4.3 Immunohematology
1.4.4 Microbiological Technique
1.4.5 Other
1.5 Market by Application
1.5.1 Global Blood Screening and Typing Market Share by Application: 2020 VS 2026
1.5.2 Reference Laboratories
1.5.3 Standalone Blood Banks
1.5.4 Hospitals
1.6 Coronavirus Disease 2019 (Covid-19): Blood Screening and Typing Industry Impact
1.6.1 How the Covid-19 is Affecting the Blood Screening and Typing Industry
1.6.1.1 Blood Screening and Typing Business Impact Assessment – Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Blood Screening and Typing Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Blood Screening and Typing Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
13.1.3 Abbott Laboratories Blood Screening and Typing Introduction
13.1.4 Abbott Laboratories Revenue in Blood Screening and Typing Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Agena Bioscience
13.2.1 Agena Bioscience Company Details
13.2.2 Agena Bioscience Business Overview and Its Total Revenue
13.2.3 Agena Bioscience Blood Screening and Typing Introduction
13.2.4 Agena Bioscience Revenue in Blood Screening and Typing Business (2015-2020)
13.2.5 Agena Bioscience Recent Development
13.3 Axo Science
13.3.1 Axo Science Company Details
13.3.2 Axo Science Business Overview and Its Total Revenue
13.3.3 Axo Science Blood Screening and Typing Introduction
13.3.4 Axo Science Revenue in Blood Screening and Typing Business (2015-2020)
13.3.5 Axo Science Recent Development
13.4 Bag Health Care Gmbh
13.4.1 Bag Health Care Gmbh Company Details
13.4.2 Bag Health Care Gmbh Business Overview and Its Total Revenue
13.4.3 Bag Health Care Gmbh Blood Screening and Typing Introduction
13.4.4 Bag Health Care Gmbh Revenue in Blood Screening and Typing Business (2015-2020)
13.4.5 Bag Health Care Gmbh Recent Development
13.5 Becton, Dickinson
13.5.1 Becton, Dickinson Company Details
13.5.2 Becton, Dickinson Business Overview and Its Total Revenue
13.5.3 Becton, Dickinson Blood Screening and Typing Introduction
13.5.4 Becton, Dickinson Revenue in Blood Screening and Typing Business (2015-2020)
13.5.5 Becton, Dickinson Recent Development

and more

Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Continued…

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: 841 198 5042
Website: https://www.wiseguyreports.com/reports/5416645-covid-19-impact-on-global-blood-screening-and

Source URL: https://marketersmedia.com/blood-screening-and-typing-market-2020-global-analysis-opportunities-and-forecast-to-2026/88963982

Source: MarketersMedia

Release ID: 88963982

Avian Flu Treatment Market 2020 Global Covid-19 Impact Analysis, Trends, Opportunities and Forecast to 2026

Wiseguyreports.Com Publish New Market Research Report On-“Covid-19 Impact on Avian Flu Treatment Market 2020 Global Analysis, Size, Share, Trends, Opportunities and Growth, Forecast 2026”

Pune, India – June 17, 2020 /MarketersMedia/

Avian Flu Treatment Market 2020

Overview
This report assembles a sweeping inquiry of the best up-to-date inclinations recognized in the Avian Flu Treatment market. It integrates a brief but educative summary, which sorts the likelihood of the report in the Avian Flu Treatment market, its primary function, as well as the methodologies in use. The viewpoint of the Avian Flu Treatment market quantified by the experts separates the market condition along with the cutting-edge industry trends in the noteworthy regions of the global market. In addition, the report provides the overhead boundaries of the product, following the risks confronted by the players in the Avian Flu Treatment market. Additionally, the global Avian Flu Treatment market report contributes to a careful consideration of the diverse forces at work that is boosting the Avian Flu Treatment market. The report offers comprehension of the market state and the estimated forecast period up to 2026.

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/4512056-global-avian-flu-treatment-market-2019-by-company

Key Players
The report expands the outlook on the market’s background along with the advanced trends swaying the domain. The report further focuses on the well-known vendors increasing the market share, which exemplifies the pioneering competitors’ input to the market.

The top players covered in Avian Flu Treatment Market are:
Macleods Pharmaceuticals
Pfizer
Forrest Pharmaceuticals
BioCryst Pharmaceuticals
Abbott
Cipla
Sanofi
GlaxoSmithKline
Gilead Sciences
Roche
Sinovac Biotech.

Drivers and Risks
The report also accentuates the several volume trends with the market documentation as well as the market estimates in addition to producing cognizance of the vital dynamics defining the Avian Flu Treatment market. A collection of budding expansion phases, threats, and forecasts are also estimated to get a visibly tuned perception of the Avian Flu Treatment market.

Regional Description
The regional study of the Avian Flu Treatment market has a noteworthy goal of considering the market degree of growth and handling the forecasts concerning growth, which is imperative across the specified regions. The report also contains the data of regions like Latin America, North America, Asia Pacific, Europe, and the Middle East & Africa with the estimates of market enhancement judged for the future. The results of the Avian Flu Treatment market trends are done with all these regions to add in the aspects of outlook, the latest trends, and circumstances in the analysis period finishing in 2019. The study of the Avian Flu Treatment market assigns feasible strategies to several regions on a global stage, where top companies have a leaning towards using returns through partnerships in only some regions.

Method of Research
The Avian Flu Treatment market is scrutinized on the basis of a combination of dynamics that summarized in Porter’s Five Force Model during the forecast period to produce a broad understanding. Besides, the data professionals are also using the SWOT based on which the report is made adept at giving out exact points about the Avian Flu Treatment market. The inclusive analysis of the market backs the documentation of its focal fortes, threats, and possibilities.

For Customisation and Query @ https://www.wiseguyreports.com/enquiry/4512056-global-avian-flu-treatment-market-2019-by-company

Table of Contents –Analysis of Key Points
1 Market Overview
2 Manufacturers Profiles
3 Global Avian Flu Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2018-2019)
4 Global Avian Flu Treatment Market Analysis by Regions
5 North America Avian Flu Treatment by Country
6 Europe Avian Flu Treatment by Country
7 Asia-Pacific Avian Flu Treatment by Country
8 South America Avian Flu Treatment by Country
9 Middle East and Africa Avian Flu Treatment by Countries
10 Global Avian Flu Treatment Market Segment by Type
11 Global Avian Flu Treatment Market Segment by Application
12 Avian Flu Treatment Market Forecast (2020-2026)
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
List of Tables and Figures
Continued…..

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +162 825 80070 (US) +44 203 500 2763 (UK)
Website: http://www.wiseguyreports.com

Source URL: https://marketersmedia.com/avian-flu-treatment-market-2020-global-covid-19-impact-analysis-trends-opportunities-and-forecast-to-2026/88963979

Source: MarketersMedia

Release ID: 88963979

Face Cream Market 2020 Global Trends, Market Share, Industry Size, Growth, Sales, Opportunities, and Market Forecast to 2026

New Study Reports “Face Cream Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports.

Pune, India – June 17, 2020 /MarketersMedia/

Face Cream Market 2020-2026

New Study Reports “Face Cream Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports.

Introduction/Report Summary:

This report provides in depth study of “Face Cream Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Face Cream Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.

Drivers and Constraints

The fundamental dynamics that are explored in the report hold substantial influence over the Face Cream market. The report further studies on the value, volume trends, and the pricing history of the market. In addition to it, various growth factors, restraints, and opportunities are also analyzed for the market to study the in-depth understanding of the market.

This report also analyzes the impact of Coronavirus COVID-19 on the Face Cream industry.

Key Players

The report has profiled some of the Important players prevalent in the global like – Helena Rubinstein, Lancome, Biotherm, LOreal Paris, kiehls, shu uemura, Olay, La Mer, Estee Lauder, Clinique, Origins, Guerlain, Dior, Sulwhasoo, Innisfree, HERA, and more.

This report covers the sales volume, price, revenue, gross margin, manufacturers, suppliers, distributors, intermediaries, customers, historical growth and future perspectives in the Face Cream.

Request for Free Sample Report of “Face Cream” Market @  https://www.wiseguyreports.com/sample-request/5356430-covid-19-impact-on-face-cream-market-global-research-reports-2020-2021

Market Segmentation based On Type, Application and Region:

The global Face Cream is analyzed for different segments to arrive at an insightful analysis. Such segmentation has been done based on type, application, and region.

Based on Type, the global Face Cream Market is segmented into Skin Whitening, Moisturizing, Repair and other

Based on Application, the Face Cream Market is segmented into Male, Female, and Others.

Based on Detailed Regional Analysis, the regional segmentation has been carried out for regions of U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America. The report on WGR includes an in-depth study of the Face Cream in each regional segment mentioned above.

Key Stakeholders 
Face Cream Market Manufacturers 
Face Cream Market Distributors/Traders/Wholesalers 
Face Cream Market Subcomponent Manufacturers 
Industry Association 
Downstream Vendors

If you have any special requirements, please let us know and we will offer you the report as you want.

Complete Report Details@ https://www.wiseguyreports.com/reports/5356430-covid-19-impact-on-face-cream-market-global-research-reports-2020-2021

Major Key Points from Table of Content:

1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Face Cream Industry
1.7 COVID-19 Impact: Face Cream Market Trends

7 Company Profiles
7.1 Helena Rubinstein
7.1.1 Helena Rubinstein Business Overview
7.1.2 Helena Rubinstein Face Cream Quarterly Production and Revenue, 2020
7.1.3 Helena Rubinstein Face Cream Product Introduction
7.1.4 Helena Rubinstein Response to COVID-19 and Related Developments
7.2 Lancome
7.2.1 Lancome Business Overview
7.2.2 Lancome Face Cream Quarterly Production and Revenue, 2020
7.2.3 Lancome Face Cream Product Introduction
7.2.4 Lancome Response to COVID-19 and Related Developments
7.3 Biotherm
7.3.1 Biotherm Business Overview
7.3.2 Biotherm Face Cream Quarterly Production and Revenue, 2020
7.3.3 Biotherm Face Cream Product Introduction
7.3.4 Biotherm Response to COVID-19 and Related Developments
7.4 LOreal Paris
7.4.1 LOreal Paris Business Overview
7.4.2 LOreal Paris Face Cream Quarterly Production and Revenue, 2020
7.4.3 LOreal Paris Face Cream Product Introduction
7.4.4 LOreal Paris Response to COVID-19 and Related Developments
7.5 kiehls
7.5.1 kiehls Business Overview
7.5.2 kiehls Face Cream Quarterly Production and Revenue, 2020
7.5.3 kiehls Face Cream Product Introduction
7.5.4 kiehls Response to COVID-19 and Related Developments

and more

Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Continued…

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: 841 198 5042
Website: https://www.wiseguyreports.com/reports/5356430-covid-19-impact-on-face-cream-market-global-research-reports-2020-2021

Source URL: https://marketersmedia.com/face-cream-market-2020-global-trends-market-share-industry-size-growth-sales-opportunities-and-market-forecast-to-2026/88963988

Source: MarketersMedia

Release ID: 88963988

Property Mavens Provides Homebuyers with Expert Advice as the Most Sought-After Buyer’s Agents in Melbourne

The company aims to ensure homeowners are getting unbiased professional advice when buying a property.

June 17, 2020

Melbourne, Australia – Property Mavens is pleased to announce it is providing home buyers with expert advice as the one of the most trending buyer’s agents in the Melbourne area.

Property Mavens is a multi-award-winning Melbourne property advocacy firm dedicated to providing clients with independent, evidence-based advice. The company aims to get home buyers into the home of their dreams, while meeting each client’s preferred budget and criteria.

“As buyer’s agents with years of experience in the industry, we’ve found that too many buyers pay more than they need to because they truly don’t understand the real estate sales process,” says CEO and founder of Property Mavens, Miriam Sandkuhler. “Additionally, many home buyers purchase based on emotions or because they lack specialist negotiation skills. Buying emotionally leads to mistakes. At Property Mavens, we find clients the right Melbourne investment property or home and are fearless when it comes to negotiating the best price and terms for our clients.”

To help clients find their ideal home, Property Mavens offers multiple packages for buyers to choose from, based on their specific needs. These packages include:

Gold – Full-Service Package
Silver – Assess and Negotiate Package
Bronze – Auction Bidding or Negotiation Only

“Whether you are a first-time homebuyer and need help throughout the entire journey, or if you simply need us to help assess the property and negotiate on your behalf, we can help,” Sandkuhler states. “Speak to one of our expert Property Mavens Property Advocates and start building sustainable wealth through property today.”

For more information about Property Mavens, or to contact an advisor, please visit the company’s website at www.propertymavens.com.au.

About the Company

Property Mavens advocates are multi-award-winning, industry-recognized Licensed Estate Agents who are engaged and paid by the buyer to work exclusively on the behalf of each client. The company provides impartial and unbiased advice and expertise to help clients save time, money, and stress.

Contact Info:
Name: Miriam Sandkuhler
Email: Send Email
Organization: Property Mavens
Phone: +61 3 9988 2266
Website: http://www.propertymavens.com.au

Release ID: 88963957

TvFix Caster Launch, Turning a Regular TV Into a Smart TV

SEATTLE, WA / ACCESSWIRE / June 17, 2020 / Think Tech announces the launching of TVFix Caster, which can allow users to turn the regular TV into a smart TV. This streaming device plugs into the back of the TV using the HDMI port. After turning on the device, it links to the home Wi-Fi connection, turning the TV into a smart device.

Imagine relaxing at home, and feeling like catching up on season three of "Ozark" what will Marty get up to this season? Streaming some favorite TV shows through a laptop or mobile device is cool, but wouldn't it be great to be able to watch it on the big screen TV in the lounge? That 6-inch cellphone display isn't doing the eyes any good. For many who don't have a smart TV, they'll have to watch on their phone. With the TV Fix streaming device anyone can turn their regular TV into a smart TV.

Sound good? The TVFix Caster reviews unpack the details on this revolutionary technology, giving everything anyone needs to know about this innovation in home entertainment.

What is TVFix Caster?

TVFix Caster allows users to turn the regular TV into a smart TV through this user-friendly and affordable device.

Essentially, any TV can become a mirror screen for the smart device. Just cast from the phone, tablet, or laptop directly to the TV screen through the streaming device. Now it's time to watch YouTube videos, torrents, and stream Netflix, all straight to the big screen TV!

Why spend thousands of dollars on a new smart TV if the regular TV is working fine? This new product is a fraction of the cost of a new TV, and anyone can get all the benefits of a smart TV, without the expensive price tag. In our TV Fix Caster reviews, we put this device to the test, and the results were stupendous.

To help customers acquire their TVFix Caster, the company is offering a special price reduction on each pack option:

Four TVFix Caster for Entertain the Whole Family Pack = $137.47 (discount pricing from $274.94)
Three TVFix Caster for Triple The Entertainment Pack = $112.48 (discount pricing from $224.96)
Two TVFix Caster for Double The Entertainment Pack = $99.98 (discount pricing from $199.96)
One TVFix Caster for Basic Pack = $49.99 (discount pricing from $99.98)

Does TVFix Caster work?

TVFix Caster works like a dream. It features easy setup, and people can get everything they need with this new casting device to plug-and-play right out of the box. There's no software required for the installation; it can be used right away.

Follow this step-by-step guide for setting up the TV Fix Caster.

Step 1 – Unbox the TV Fix streaming device

Step 2 – Insert it into the HDMI port of the TV

Step 3 – Connect the deviceto the USB charger included in the package

Step 4 – Switch the TV settings to HDMI

Step 5 – Pair the device to the home Wi-Fi network

Step 6 – Start streaming all the favorite shows and movies, using the phone to control it!

The entire setup process will take less than 5-minutes. The best part is that there's no software installation needed and no complicated setup procedure. The device pops up on the home's Wi-Fi device list in seconds, and the connection strength is awesome.

After completing the setup, it's time to take the device for a spin. Load up a YouTube video on the phone. And it appears on the TV screen. Just use the phone as the controller, and the casting device will receive all the commands and instructions, with a lightning-fast connection that never lets anyone down.

TVFix Caster reviews show this is the real deal

"TVFix Caster is a sham". It's understandable how some people might think that this piece of tech is a fraud. But anyone can prove and read in all the TV Fix Caster reviews that customers are impressed with the quality and efficiency of this streaming device.

Connect the TV to the internet for less than it costs for a month of cable? That sounds too good to be true. The reality is that the device works, and it's an affordable and effective way of upgrading any TV without breaking the bank account.

TVFix Caster reviews show users that this device is the real deal. It delivers on its promises of streaming directly to the TV. The only reason people think this is a TV Fix sham is they don't read the manual and think they can get instant free TV from anywhere in the world.

TVFix Caster vs Chromecast

TV Fix Caster is superior to Chromecast. There was a time when Google Chromecast was the gold standard for this technology. But anyone who has used one knows that it drops the connection between the device and TV all the time.

Among the positive aspects of this device are:

Stream movies, TV shows, series, and games directly from the device to the TV
No need for a smart TV – The TVFix device connects to the current regular TV
Wireless support for more than 2,000 video entertainment apps
Multiple play modes, including AirPlay, DLNA, Miracast, AirMirror, cross-system, and cross-terminal screen mirroring
More affordable than cable – costs less than one moths subscription to a cable service
Money-back guarantee
Plug-and-play setup
High quality tech specs

The downsides are:

It needs WiFi or internet connection (but honestly, everyone has WiFi)
They sell out fast
Their sales offers usually don't last for too long

Chromecast is like a dinosaur compared to TV Fix Caster. The tech used in the design and manufacture of this casting device has more advanced components and plays everything in full HD. The quality is far superior to what you get with Chromecast, and best of all, it doesn't spy on people like Google Chromecast!

What can users watch on TVFix Caster?

TVFix Caster gives access to any form of media that can be played on the phone or mobile device. From streaming, Netflix and Amazon Prime to watching all the favorite torrents and playing YouTube videos, whatever customers can do on their phone, they can do it on their TVFix streaming device.

With excellent quality and such a wide selection available for the viewing pleasure, many more people will probably cancel their cable subscription.

The company wraps up TVFix Caster reviews with their final verdict on whether they recommend purchasing this product. This new casting device is everything anyone would love to have to kick up their home entertainment a few notches. It can connect the TV to the internet via the smart device for far less than the price of a monthly cable subscription. Know more at Official TVFix Caster Site Here.

Media contact

Company: TVFix Caster
Address: Think Tech Sales Limited 62544, G/F Bamboos Centre, 52 Hung To Road, Kwung Tong, Hong Kong
Email: support@gettvfix.com
US: +1 855 884 0385
CA: +1 844 846 5323
UK & Ireland: +44 3308 081445
AU & NZ: +61 8 7282 2000
Website: https://www.gettvfix.com

SOURCE: TVFix Caster

ReleaseID: 594313

Learning Management System Market 2020 Global Industry Trends, Sales Revenue, Segmentation, Top Leaders, Future Scope and Regional Forecast to 2022

Market Research Future published a research report on “Learning Management System Market Research Report- Global Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.

Pune, India – June 17, 2020 /MarketersMedia/

Learning Management System (LMS) Market Global Market – Overview

Learning management system (LMS) is a software application that systematizes the administration, tracking, and reporting of training events. It is a portal that enables lecturers and students to interact out of the classroom, have discussions through forums that could reduce time which is spent in the classroom. Most university nowadays are providing internet access to their students, and usually there are internet cafes within a walking distance from the university campus, so that the students can make use of learning management system (LMS). The common features of learning management system (LMS) comprise of content management, assessment and testing, curriculum planning, reports generation, communication and collaboration, and classroom and college announcements. Moreover, an LMS should integrate with other enterprise application solutions used by HR and accounting, enabling management to measure the impact, effectiveness, and overall cost of training initiatives.

The use of learning management system (LMS) has facilitated teachers and students with accessibility, but it has reduced face-to-face contacts between teachers and students, and activities which comprise an important part of the overall learning process. The learning management system (LMS) can be purchased as a direct purchase model, third-party maintenance model, or software as a service (SaaS) model depending upon the usage and application within the organization.

Get Free Sample Report @ https://www.marketresearchfuture.com/sample_request/1858

The key driving factor for learning management system (LMS) is increasing e-learning industry, growing cloud computing market, and increasing demand for cost-effective training solution by industries. The market is growing at an extraordinary rate and hence is expected to be benefitted by these drivers. However, due to lack of awareness about learning management system (LMS) software, the market may face a huge setback. Universities are facing a major challenge of enrolling students in their education program as well as expanding their infrastructure to accommodate increased students and support learning and faculty teaching.

Key Players for learning Management System Market:

Some of the major players in Global Learning Management System Market includes Edmodo (California), Blackboard, Inc. (U.S.), IBM corporation (U.S.), SAP SE (Germany), Xerox corporation (U.S.), Oracle Corporation (U.S.), McGraw-Hill Education (U.S.), Cornerstone On demand, Inc. (U.S.), D2L Corporation (Canada), and Saba Software, Inc. (U.S.) among others.

Learning Management System Market – Segmentation

The Global Learning Management System Market is segmented in to 4 key dynamics for the convenience of the report and enhanced understanding;

• Segmentation By Services: Comprises content management, Performance management, administration, communication & collaboration among others.
• Segmentation By Deployment: Comprises Cloud and on-premise.
• Segmentation By Application: Comprises Corporate, and academics among others.
• Segmentation By Regions: Comprises Geographical regions – North America, Europe, Asia Pacific and Rest of the World.

Learning Management System (LMS) Market Global Market – Regional Analysis

The regional analysis of learning management system (LMS) Market is studied for North America, Europe, Asia Pacific and Rest of the World. The educational sector is flourishing in countries such as U.S. and Canada, resulting in the higher adoption of online learning services by universities. This results in the dominance of North America in learning management system (LMS) market. Additionally, higher immigration of students from different developing countries to United States has increased the use of learning management system (LMS) for the purpose of gaining education by online means.

Asia-Pacific is expected to be the fastest growing region for learning management system (LMS) market owing to increased demand by organization for cost-effective learning system to train their employees which would give better ROI in the future. Hence, the key players in the market are constantly innovating and investing in research and development activities in order to create cost-effective product portfolio.

Get Complete Report @ https://www.marketresearchfuture.com/reports/learning-management-system-market-1858

Table of Contents:

1. Report Prologue

2. Introduction

2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure

3. Research Methodology

3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model

4. Market Dynamics

4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges

5. Market Factor Analysis

5.1 Value Chain Analysis/Supply Chain Analysis
5.2 Porters Five Forces

Continued…

Get New Updates @ https://www.linkedin.com/company/ict-mrfr

About Us:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: ABHISHEK SAVANT
Email: Send Email
Organization: Market Research Future
Website: https://www.marketresearchfuture.com/

Source URL: https://marketersmedia.com/learning-management-system-market-2020-global-industry-trends-sales-revenue-segmentation-top-leaders-future-scope-and-regional-forecast-to-2022/88963924

Source: MarketersMedia

Release ID: 88963924